Literature DB >> 25313099

The threat of human influenza: the viruses, disease impacts, and vaccine solutions.

Jiehui Kevin Yin, Glenn Salkeld, Leon Heron, Gulam Khandaker, Harunor Rashid, Robert Booy1.   

Abstract

Influenza is an acute respiratory illness that remains an important cause of excessive morbidity and mortality with substantial economic cost to the population. Influenza, being a virus that frequently mutates, is not amenable to elimination. Vaccination remains the most effective preventive measure. This review summarises the latest developments in the fields of biology and epidemiology relating to clinical and economic impacts of influenza disease, and vaccination. We suggest that future efforts should focus on developing safer, more effective, and cost-effective prophylactic vaccines for influenza.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25313099     DOI: 10.2174/1871526514666141014150907

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  4 in total

1.  Prediction of Incidence Trend of Influenza-Like Illness in Wuhan Based on ARIMA Model.

Authors:  Pai Meng; Juan Huang; Deguang Kong
Journal:  Comput Math Methods Med       Date:  2022-07-12       Impact factor: 2.809

2.  Epidemic situation of the complex seasonality of imported influenza A and B virus transmission in Guangxi ports of China

Authors:  Xiangjuan Li; Zhongping Liang; Jie Gan; Lingmin Lu
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

3.  A comprehensive study on cellular RNA editing activity in response to infections with different subtypes of influenza a viruses.

Authors:  Yingying Cao; Ruiyuan Cao; Yaowei Huang; Hongxia Zhou; Yuanhua Liu; Xuan Li; Wu Zhong; Pei Hao
Journal:  BMC Genomics       Date:  2018-01-19       Impact factor: 3.969

4.  Time series analysis of influenza incidence in Chinese provinces from 2004 to 2011.

Authors:  Xin Song; Jun Xiao; Jiang Deng; Qiong Kang; Yanyu Zhang; Jinbo Xu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.